Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Christmas Dinner Warning for Ozempic Users: 'Food Was Bubbling Up' - Featured image
Health

Christmas Dinner Warning for Ozempic Users: 'Food Was Bubbling Up'

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·4 min read

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

Allison Rankin recounts her experience of discomfort and vomiting after overeating at a family Christmas dinner while taking Mounjaro. Doctors caution against overeating on weight loss drugs due to slowed digestion.

Share

Christmas Dinner Warning for Ozempic Users: 'Food Was Bubbling Up'

Allison Rankin was looking forward to her family's annual Christmas gathering.

In 2022, she traveled to Indiana, where her aunt transformed her living room and garage to accommodate the extended family of 60 for the holiday.

However, that particular year was different because Rankin, then 45 and residing in Boston, Massachusetts, had recently begun taking Mounjaro, a weight-loss medication.

Having been on the medication for roughly three months, she had shed 20lbs from her initial weight of 190lbs, bringing her closer to the obese range for her 5ft 7in frame.

Upon arriving at the party, she chose to keep her medication use private, as the drug was scarce at the time, and she feared accusations of depriving type 2 diabetics, for whom the drug was originally intended.

Rankin acted normally, greeting relatives and enjoying a glass of champagne before filling her plate with macaroni and cheese, pie, turkey, and gravy.

In a recent interview, she recalled that about an hour after starting her meal, she felt something was amiss.

'I just had that feeling... that feeling where you are going to throw up,' she explained. 'I felt like if I could throw up right then, I would. There was enough food bubbling at the top of my throat.'

She had eaten too much.

Physicians advise against overeating while using weight loss medications because these drugs slow down the digestive process, potentially leading to vomiting.

'When you overindulge at a buffet, you can usually just breathe through it,' Rankin, now 48, stated.

'But on a GLP-1, that won't happen. The food simply sits in your stomach. I experienced the [cold sweat] and the sensation of being about to explode.'

She recounted going pale, experiencing alternating chills and hot flashes, before excusing herself to the restroom.

Once in the bathroom, Rankin induced vomiting, expelling the undigested meal.

'It was solid food,' she remembered. 'It hadn't digested at all.'

After cleaning up, Rankin returned to the party and continued eating. She mentioned that no one noticed the incident.

This was the second instance of Rankin privately vomiting at a family gathering while on the drug. The first occurred at Thanksgiving after starting Mounjaro in late September 2022. She reported identical experiences at both events. Health tracking apps like Shotlee can help monitor eating habits and potential side effects.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

Rankin shed 50lbs in six to eight months using Mounjaro and Zepbound, both containing the active ingredient tirzepatide.

Rankin had been trying to lose weight for years. She had tried the Atkins and Paleo diets, as well as reducing her calorie intake, but she said that nothing had worked.

She often worried about her health because of her weight. Many members of her family were at least 40 to 50lbs overweight, and several had heart problems.

Her father and uncle had experienced heart attacks, while her aunt and sister both required a quadruple bypass.

After starting Mounjaro, Rankin initially made mistakes, such as consuming only 600 calories daily due to a lack of hunger. She also suffered from nausea as a symptom, though she had not vomited previously.

Following these vomiting episodes, Rankin, who co-founded MyCompanionBox, a company providing food samples to weight-loss drug users, made changes. She began eating protein-rich meals and attending exercise classes.

Rankin lost 50lbs in six to eight months on Mounjaro and Zepbound (another GLP-1 agonist), averaging about 7lbs per month. After reaching her target weight of 140lbs, she gained back 10lbs because friends thought she looked gaunt.

She currently takes 10mg of Zepbound weekly and plans to continue the medication.

Rankin now feels more comfortable with her medication use and weight management.

She now selects only the foods she wants to eat and spreads them out on her plate, leaving empty space to avoid overfilling it.

However, dealing with unsolicited advice remains challenging.

'In my family, nothing is ever quite right, and they'll comment on everything you do,' she stated.

'If you're overweight and eat too much, they criticize you. If you're skinnier, they tell you to eat more because they aren't used to seeing you eat like a thin person.'

After years of practice, Rankin has achieved self-acceptance.

'I openly share my GLP-1 use and my involvement in a GLP-1-related business. It has helped me, and I'm comfortable with that,' she said.

'By discussing it, I hope to educate others who are worried or curious about the drug.'

Source Information

Originally published by Daily Mail Online.Read the original article →

Read next

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

Ozempic Price Cut: Generic Semaglutide Arrives in Canadian Pharmacies
Health & Wellness

Ozempic Price Cut: Generic Semaglutide Arrives in Canadian Pharmacies

Two generic versions of Ozempic have arrived in Canadian pharmacies, offering diabetes and weight loss patients significant cost savings compared to the brand-name medication.

7 min read
Retatrutide Breaks Records: What Phase 3 TRIUMPH-1 Data Means
Health & Wellness

Retatrutide Breaks Records: What Phase 3 TRIUMPH-1 Data Means

Eli Lilly's Retatrutide has shown remarkable weight loss potential in Phase 3 trials. We break down the TRIUMPH-1 results, safety data, and what patients can expect.

9 min read
Driving on Ozempic & Mounjaro: Avoiding the £1,000 DVLA Fine
Health & Wellness

Driving on Ozempic & Mounjaro: Avoiding the £1,000 DVLA Fine

New regulations warn that GLP-1 medication users could face significant fines if side effects impair driving. Here is the complete guide to staying safe and compliant.

8 min read

Same topic: weight loss drugs

All weight loss drugs articles →
Wegovy Pill in New Jersey Stores: Where to Obtain It
Health

Wegovy Pill in New Jersey Stores: Where to Obtain It

The new Wegovy GLP-1 pill for weight loss is now accessible in New Jersey stores. With growing interest in these medications, this guide covers availability, pricing, and key safety information. Health tracking apps like Shotlee can assist in monitoring progress during use.

2 min read
Additional side effect alert for individuals on weight-loss injections this week
Health

Additional side effect alert for individuals on weight-loss injections this week

Thousands are resuming their weight-loss drugs after holiday pauses, but experts caution about heightened side effects. Research indicates many users wait until New Year to restart regimens. Follow guidelines to avoid rebound issues and manage doses safely.

3 min read
Ozempic's Impact: Reshaping Supermarkets and Stock Valuations
Health

Ozempic's Impact: Reshaping Supermarkets and Stock Valuations

The rise in popularity of weight loss medications such as Ozempic and Mounjaro is significantly impacting both the food industry and the stock market. Eli Lilly, a pharmaceutical company, experienced a surge in valuation after reporting substantial sales increases. These drugs are changing eating patterns and redefining obesity treatment.

6 min read

More in Health

GLP-1 Drugs: Understanding the Weight Loss Revolution
Health & Wellness

GLP-1 Drugs: Understanding the Weight Loss Revolution

The advent of GLP-1 receptor agonists has transformed the landscape of weight management, offering new hope for individuals struggling with obesity. This article delves into the science, benefits, potential drawbacks, and the leading players in this groundbreaking field.

7 min read
GLP-1 Weight Loss Drugs: Eli Lilly's Next-Gen Therapies vs. Novo Nordisk
Weight Management

GLP-1 Weight Loss Drugs: Eli Lilly's Next-Gen Therapies vs. Novo Nordisk

The race for dominance in the lucrative weight loss drug market is intensifying. While Novo Nordisk's Wegovy has been a pioneer, Eli Lilly is rapidly advancing its pipeline with next-generation therapies poised to challenge the status quo. This article delves into the science, clinical data, and market implications of these groundbreaking treatments.

6 min read
Share this article
  1. Home
  2. Blog
  3. Christmas Dinner Warning for Ozempic Users: 'Food Was Bubbling Up'
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community